ASTIMLI HASTALARDA YAŞAM KALİTESİNİN DEĞERLENDİRİLMESİ

Öz

Astım, hayatı fiziksel, emosyonel ve sosyal açılardan etkileyen kronik bir hastalıktır. Son yıllarda hastalığın bu yönünü de değerlendirmek amacı ile yaşam kalitesi ölçüm formları geliştirilmiştir. Çalışmamızda astımlı hastalarda yaşam kalitesi değerlendirildi. Merkezimiz astım ve allerji polikliniğinde en az bir yıldır takip edilmekte olan ve Toraks Derneği uzlaşı raporları doğrultusunda daha önce astım tanısı almış 120 hasta çalışmaya alındı. Hastaların K/E oranı 98/22 olup, yaş ortalaması 38.19±10.99 idi. Hastalara AQ 20 ve Q Score yaşam kalitesi anket formları dolduruldu. Formlarda; soru adedi, puan değişimi ve ölçtükleri zaman süresi, sırasıyla; 20 soru/4 soru; 0-20 puan/0-8 puan; 30 gün- 7 gün idi. AQ 20 ortalaması 8.49±4.26, Q Score ortalaması 3.14±2.02 olarak bulundu. Hastalar yaşam kalitelerine göre düşük, orta, yüksek olarak sınıflandırıldığında bu değerler AQ 20 de sırası ile %20, %32.5, %47.5; Q Score da %25, %48.33, %26.66 olarak bulundu. Gece ve gündüz semptom skorları, FEV1 % değer değişimi, PEF değer değişimi ile yaşam kalitesi skorları arasında anlamlı bir ilişki bulundu (p 0.05). Sonuç olarak; astımlı hastalarda tedaviden amaç sadece akciğer fonksiyonlarının düzelmesi olmayıp, hastalığın fiziksel, emosyonel ve psikolojik boyutunu da gösteren yaşam kalitesi ölçüm sonuçlarının düzelmesi de dikkate alınmalıdır.

Anahtar Kelimeler

• Astım, yaşam kalitesi

ASSESSMENT OF QUALITY OF LIFE IN PATIENTS WITH ASTHMA

Öz

Asthma is chronic disease that affects life physically, socially and emotionally. Recently, to evaluate this aspect of the disease, life quality assessment forms are developed. In the present study, life quality of asthmatic patients are evaluated. 120 asthmatic patients that we followed in asthma and allergy clinic in our center was included in the study. The diagnosis of asthma was based on Turkish Thoracic Society recommendations. F/M was 98/22, mean age was 38.19±10.99; AQ 20 and Q score life quality questionnaire forms were filled. The forms consists of 20 questions/4 questions; 0- 20 points and 0-8 points range; 30 days-7 days respectively. AQ mean score was 8.49± 4.26, Q mean score was 3.14±2.02. Patients were categorized into three groups according to quality of life as low, intermediate and high in AQ 20 as 20%, 32.5%, 47.5% and in Q as 25%, 48.33%, 26.66% respectively. There was a significant relation between life quality scores and night and daytime symptoms, % FEV 1 and PEF values (p0.05). In conclusion, treatment aim of asthmatic patients must be not only improving of respiratory functions but also improving of quality of life measurements reflecting physical, emotional and psychological side of illness.

Anahtar Kelimeler

• Asthma, quality of life

Kaynakça

1. 1. Gruffydd K. Quality-of-life measures in asthma-do they matter to the GP? Br J Gen Pract 1997; 47: 392-4.
2. 2. Barley EA, Quirk FH, Jones PW. Asthma health status measurement in clinical practice: validity of a new short instrument. Respir Med 1998; 92: 1207-14.
3. 3. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis 1993; 147: 832-8.
4. 4. Ware JE, Sherbourne CD, Davies AR, et al. A short-Form Health Survey (SF-36) I. conceptual framework and item selection. Med Care 1992; 30: 473-83.
5. 5. Kaptein AA, Brand PLP, Dekker FW, et al. Quality-of-life in a long-term multicente trial in chronic nonspecific lung disease: assessment at baseline. Eur Respir J 1993; 6: 1479-84.
6. 6. Juniper EF, Johnston PR, Borkhoff CM, et al. Quality of life in asthma clinical trails: comparison of salmeterol and salbutamol. Am J Respir Crit Care Med 1995; 151: 66-70.
7. 7. Ulrik CS. Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single center randomized, double blind, placebo controlled, crossover study. Thorax 1995; 50: 750-4.
8. 8. Rimmigton LD, Aronosffsky L, Mowatt A, et al. Use of a simple patient focused morbitidy score. Eur Respir J 1997; 10(suppl 25): 194. 9. Nunn AJ, Gregg I. New regression equations for predicting peak expiratory flow in adults. BMJ 1989; 298: 1068-70.

9. 10. American Thoracic Society. Standardization of spirometry-1987 update. Am Rev Respir Dis 1987; 139: 1285-307.
10. 11. Knudson RJ, Lebowitz MD, Holberg CJ, et al. Changes in the normal maxial expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983; 127: 725-34.
11. 12. Osman ML, Calder C, Robertson R, et al. Symptoms, quality of life, and health service contact among young adults with mild asthma. Am J Respir Crit Care Med 2000; 161: 498-503.
12. 13. Dyer CAE, Hill SL, Stokley RA, Sinclair AJ. Quality of life in elderly subjects with a diagnostic label of asthma form general practice registers. Eur Respir J 1999; 14: 39-45.
13. 14. Marks GB, Dunn SM, Woolca AJ. A scale for the measurement of quality of life inadults with asthma. J Clin Epidemiol 1992; 45: 461-72.
14. 15. Juniper EF, Guyatt GH. evaluation of impairment of health related quality of life in asthma; Development of questionnaire for use of clinical trials. Thorax 1992; 47: 76-83.
15. 16. Schmier JK, Chan KS, Leidy NK. The impact of asthma on health-related quality of life. J Asthma 1998; 35: 585-97.
16. 17. Mishoe SC, Baker RR, Poole S, et al. Development of an instrument to assess stress levels and quality of life in children with asthma. J Asthma 1998; 357: 553-63.
17. 18. Roorda RJ, Gerritsen J, Van Aalderen WMC, et al. risk factors for the persistence of the respiratory seymtoms in childhood asthma. Am Rev Respir Dis 1993; 148: 1490-5.
18. 19. Leidy NK, Coughlin C. psychometric performance of the asthma quality of life questionnaire in a US sample. Qual Life Res 1997; 7: 127-34.
19. 20. Rimington LD, Davies DH, Lowe D, et al. relationship between anxiety, depression, and morbity in adult asthma patients. Thorax 2001; 56: 266-71.